We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.
Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Axonics Modulation Technologies brings in $32.6mm through Series A round
28 Mar 2014
Executive Summary
Axonics Modulation Technologies Inc. (implantable neuromodulation technology) raised $32.6mm via its Series A financing of preferred shares led by Edmond de Rothschild Investment Partners. NeoMed Management, Legend Capital, and private investors also participated. A member from each investment firm takes a seat on Axonics’ board.
Deal Industry
Medical Devices
Medical Devices
Implantable Devices
Deal Status
Final
Deal Type
Financing
Venture Financing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?